News

Medivation, a biopharmaceutical company, has reported new positive efficacy and safety data from an ongoing Phase I-II clinical trial of the company’s novel androgen receptor antagonist MDV3100 in

Poniard Pharmaceuticals has reported new positive efficacy and safety data from its ongoing Phase II clinical trial of picoplatin in combination with docetaxel and prednisone as first-line therapy

US-based healthcare company Abbott has opened a new nutrition product manufacturing facility in Singapore to meet increasing regional demand for its pediatric nutrition products, including Similac. The facility

Cardiovascular Systems, a medical device company, has closed its merger with a subsidiary of Replidyne. In connection with the merger, Replidyne changed its name to Cardiovascular Systems, Inc

We made a major strategic acquisition to purchase SPR technology and sold our HIFU business to become a pure advanced IVD company based in China,” commented Xiaodong Wu,

China Sky One Medical, a producer of over-the-counter drugs, has signed an agreement with Shaanxi Xintai Pharmaceutical Company to distribute the company’s Asthma Patch product. Shaanxi Xintai and

Bone Biologics has received a US Patent Office notice of allowance of patent claims which protect a method of production for the UCB-1 recombinant protein that the company

Brecher is a member of the editorial boards of Transfusion and Blood Therapies in Medicine and is an associate editor of the Journal of Clinical Apheresis. He is

The Astellas tender offer represents a 41% premium to CV Therapeutics’s closing share price on January 26, 2009, the day prior to the public disclosure of Astellas’s proposal,